期刊
EMBO JOURNAL
卷 29, 期 7, 页码 1248-1261出版社
WILEY
DOI: 10.1038/emboj.2010.21
关键词
FXTAS; RNA gain-of-function diseases; Sam68
资金
- NSERM AVENIR funding (NCB)
- ANR GENOPAT [P007942]
- NIH-NINDS [NS062411]
- NIH Roadmap Initiative [DE019583, AG032119]
- BBSRC [BB/D013917/1]
- Wellcome Trust [WT080368MA]
- ORSAS international studentship
- Biotechnology and Biological Sciences Research Council [BB/D013917/1] Funding Source: researchfish
- BBSRC [BB/D013917/1] Funding Source: UKRI
Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) is a neurodegenerative disorder caused by expansion of 55-200 CGG repeats in the 5'-UTR of the FMR1 gene. FXTAS is characterized by action tremor, gait ataxia and impaired executive cognitive functioning. It has been proposed that FXTAS is caused by titration of RNA-binding proteins by the expanded CGG repeats. Sam68 is an RNA-binding protein involved in alternative splicing regulation and its ablation in mouse leads to motor coordination defects. Here, we report that mRNAs containing expanded CGG repeats form large and dynamic intranuclear RNA aggregates that recruit several RNA-binding proteins sequentially, first Sam68, then hnRNP-G and MBNL1. Importantly, Sam68 is sequestered by expanded CGG repeats and thereby loses its splicing-regulatory function. Consequently, Sam68-responsive splicing is altered in FXTAS patients. Finally, we found that regulation of Sam68 tyrosine phosphorylation modulates its localization within CGG aggregates and that tautomycin prevents both Sam68 and CGG RNA aggregate formation. Overall, these data support an RNA gain-of-function mechanism for FXTAS neuropathology, and suggest possible target routes for treatment options. The EMBO Journal (2010) 29, 1248-1261. doi:10.1038/emboj.2010.21; Published online 25 February 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据